FDA-cleared profile

ChestView US

Gleamer SAS · X-ray/Radiography · FDA-cleared (510(k))

Authorized purpose: Concurrent reading aid for adult frontal and lateral chest radiographs, marking suspected nodules, pleural-space abnormalities, mediastinal/hilar abnormalities and consolidations.

Clinical role
Concurrent reading aid that presents annotated output for radiologist or emergency-physician review; final interpretation remains with the clinician.
Images and patients
X-ray/Radiography · Chest/Lung
Key limitation
Keep in mind: The product is an aid and does not replace clinician interpretation. Output labels include NO CHESTVIEW ROI and OUT OF SCOPE when the algorithm cannot provide a relevant result; the cleared scope is adult frontal/lateral chest radiography and listed findings.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Concurrent reading aid for adult frontal and lateral chest radiographs, marking suspected nodules, pleural-space abnormalities, mediastinal/hilar abnormalities and consolidations.
  • Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Chest/Lung Input: Adult frontal and lateral chest X-ray examinations received as DICOM; the submission describes the cleared thoracic regions and listed findings.
  • Who uses it?Intended users: Radiologists, emergency physicians and other qualified healthcare professionals interpreting adult chest radiographs.
  • What does the software produce?Output: Annotated DICOM output with boxes labeled Nodule, Pleural space abnormality, Mediastinum/Hila abnormality and Consolidation. Solid-line boxes indicate higher specificity and dotted-line boxes indicate higher sensitivity; NO CHESTVIEW ROI and OUT OF SCOPE states are also displayed.
  • What is its most important limitation?Key limitation: The product is an aid and does not replace clinician interpretation. Output labels include NO CHESTVIEW ROI and OUT OF SCOPE when the algorithm cannot provide a relevant result; the cleared scope is adult frontal/lateral chest radiography and listed findings.

Clinical takeaway. Clinical role: Concurrent reading aid for adult frontal and lateral chest radiographs, marking suspected nodules, pleural-space abnormalities, mediastinal/hilar abnormalities and consolidations.

Evidence takeaway. Evidence from the reviewed source record: The FDA packet defines the annotated outputs and intended thoracic findings but the reviewed summary did not yield a single consolidated performance number suitable for this dossier.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Concurrent reading aid for adult frontal and lateral chest radiographs, marking suspected nodules, pleural-space abnormalities, mediastinal/hilar abnormalities and consolidations.
  • Exact FDA submission
  • Checked 2026-09-07
Workflow role
Concurrent reading aid that presents annotated output for radiologist or emergency-physician review; final interpretation remains with the clinician.
  • Exact FDA submission
  • Checked 2026-09-07
Required input
Adult frontal and lateral chest X-ray examinations received as DICOM; the submission describes the cleared thoracic regions and listed findings.
  • Exact FDA submission
  • Checked 2026-09-07
Output and clinician action
Annotated DICOM output with boxes labeled Nodule, Pleural space abnormality, Mediastinum/Hila abnormality and Consolidation. Solid-line boxes indicate higher specificity and dotted-line boxes indicate higher sensitivity; NO CHESTVIEW ROI and OUT OF SCOPE states are also displayed.
  • Exact FDA submission
  • Checked 2026-09-07
Care setting
Hospital and outpatient imaging services using adult frontal and lateral chest radiography.
  • Exact FDA submission
  • Checked 2026-09-07
Intended users
Radiologists, emergency physicians and other qualified healthcare professionals interpreting adult chest radiographs.
  • Exact FDA submission
  • Checked 2026-09-07
Limitations
The product is an aid and does not replace clinician interpretation. Output labels include NO CHESTVIEW ROI and OUT OF SCOPE when the algorithm cannot provide a relevant result; the cleared scope is adult frontal/lateral chest radiography and listed findings.
  • Exact FDA submission
  • Checked 2026-09-07
Evidence summary
The FDA packet defines the annotated outputs and intended thoracic findings but the reviewed summary did not yield a single consolidated performance number suitable for this dossier.
  • Exact FDA submission
  • Checked 2026-09-07

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The FDA packet defines the annotated outputs and intended thoracic findings but the reviewed summary did not yield a single consolidated performance number suitable for this dossier.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-07
Reported sensitivity
95%
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-13

Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.

Reported specificity
95%
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-13

Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

ChestView US K241620 validation

  • DesignRegulatory performance validation described in the FDA 510(k) summary
  • PopulationAdult frontal and lateral chest radiographs with the listed thoracic findings
  • Scopeexact submission
  • Tested versionChestView US configuration submitted in K241620
  • IndependenceSponsor or vendor study

K241620

The dossier retains the cleared outputs and limitations without inventing a consolidated sensitivity or specificity value.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-07

The downloaded exact-ID recall packet contained zero records; this limited result does not establish absence of recall or safety information.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Adult frontal and lateral chest X-ray examinations received as DICOM; the submission describes the cleared thoracic regions and listed findings.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-07 · FDA 510(k) K241620: ChestView US

  2. Routing

    Source context, not route validation: DICOM chest radiographs are processed and returned with annotated output for review in the radiology workflow; exact local worklist and PACS routing require site confirmation.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-07 · FDA 510(k) K241620: ChestView US

  3. AI processing

    Source context, not route validation: The FDA submission describes a software workflow that receives chest radiographs and returns annotated DICOM images; the public summary does not establish a particular hosting model.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-07 · FDA 510(k) K241620: ChestView US

  4. Returned objects

    Source context, not route validation: Annotated DICOM output with boxes labeled Nodule, Pleural space abnormality, Mediastinum/Hila abnormality and Consolidation. Solid-line boxes indicate higher specificity and dotted-line boxes indicate higher sensitivity; NO CHESTVIEW ROI and OUT OF SCOPE states are also displayed.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-07 · FDA 510(k) K241620: ChestView US

  5. Viewer/worklist/report

    Unresolved route: Annotated DICOM output with boxes labeled Nodule, Pleural space abnormality, Mediastinum/Hila abnormality and Consolidation. Solid-line boxes indicate higher specificity and dotted-line boxes indicate higher sensitivity; NO CHESTVIEW ROI and OUT OF SCOPE states are also displayed.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-07 · FDA 510(k) K241620: ChestView US

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The FDA submission describes a software workflow that receives chest radiographs and returns annotated DICOM images; the public summary does not establish a particular hosting model.
  • Exact FDA submission
  • Checked 2026-09-07
Integration
DICOM chest radiographs are processed and returned with annotated output for review in the radiology workflow; exact local worklist and PACS routing require site confirmation.
  • Exact FDA submission
  • Checked 2026-09-07

Annotated DICOM findings

The cleared output adds labeled boxes and explicit NO CHESTVIEW ROI or OUT OF SCOPE states for clinician review.

exact submission · checked 2026-09-07

Worklist and shadow-mode workflow

The current ChestView family page describes native workflow integration, worklist support and shadow-mode evaluation for deployment planning.

product family · checked 2026-09-06

These family capabilities do not establish exact K241620 hosting, performance or service terms.

Current family label reference

Gleamer publishes a ChestView v1.0.1-US label with current product-family scope and labeling information.

product family · checked 2026-09-06

The public label was not used to overwrite the K241620 FDA submission identity.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K241620
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
X-ray/Radiography
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-07
Anatomy
Chest/Lung
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-07
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-02-27
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-07Last searched
24Fields reviewed
11Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

Stored candidate metadata was screened; no PubMed or trial IDs were returned for this submission. This is not a full-paper review. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, vendor label, stored candidate metadata, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-07 - Exact FDA submission

    No public price or quote for ChestView US was reviewed.

  • Pricing model: Not verified - checked 2026-09-07 - Exact FDA submission

    License, per-study, subscription and implementation terms were not established.

  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "Gleamer ChestView reimbursement"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-07 - Exact FDA submission

    The reviewed public sources do not establish exact-release security controls, retention or assurance documentation.

  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-10-27 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-10-27 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

8 sources - 3 history items

Source ledger

  1. FDA 510(k) K241620: ChestView US

    U.S. Food and Drug Administration - Accessed 2026-09-07

    Scope: identity, purpose, clinicalUse, modality, anatomy, workflowRole, intendedUsers, careSetting, input, output, limitations, integration, deployment, evidenceStudies

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. ChestView US model card (K241620)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. ChestView | Gleamer

    Gleamer - Accessed 2026-09-06

    Scope: productFamilyContext, clinicalUse, implementationCapabilities

  8. ChestView v1.0.1-US label

    Gleamer - Accessed 2026-09-06

    Scope: productVersion, productFamilyContext

Research history

  1. K241620 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K190362

HealthPNX

Zebra Medical Vision Ltd.

Authorized purpose: Automatically analyzes PA/AP chest X-rays for suspected pneumothorax and alerts PACS or a worklist.

Modality
X-ray/Radiography
Anatomy
Chest/Lung
Decision
2019-05-06
FDA-cleared K111776

DELTAVIEW MODEL 2.1

RIVERAIN MEDICAL GROUP,LLC

Authorized purpose: Registers current and prior chest examinations to create a secondary residual image showing areas of change.

Modality
X-ray/Radiography
Anatomy
Chest/Lung
Decision
2011-12-28
FDA-cleared K243831

Rayvolve LN

AZmed

Authorized purpose: Second-reader support for radiologists reviewing adult digital AP or PA chest radiographs, with suspected pulmonary nodules in the 6-30 mm range marked for review.

Modality
X-ray/Radiography
Anatomy
Chest/Lung
Decision
2025-03-26
FDA-cleared K243808

Rayvolve PTX-PE

AZmed

Authorized purpose: Passive study-level worklist triage for suspected pneumothorax and/or pleural effusion on adult PA or AP chest X-rays; it is not a proactive specialist alert.

Modality
X-ray/Radiography
Anatomy
Chest/Lung
Decision
2025-03-21

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history